Search
Displaying 231–240 of 1066 results
-
Ocugen Reports Updated Results for Clinical Trial of Modifier Gene Therapy
Research NewsThe company is also launching modifier gene therapy clinical trials for GA and Stargardt disease
-
Eye on the Cure Podcast | Episode 53: David Birch, PhD
Eye on the CureDavid Birch, PhD, at the Retina Foundation of the Southwest in Dallas, talks to host Ben Shaberman about his productive and impactful 40-plus-year career as a retinal disease researcher and clinical trial investigator. Dr. Birch also discusses the challenges and opportunities for advancing more therapies through trials and out to the people who need them.
-
The CRB1 Landscape Document provides an overview of Crumbs homolog-1/CRB1 at multiple levels: the gene, the protein, its function, and the epidemiology and clinical manifestations of CRB1-associated disease, as well as potential treatment strategies, with a focus on the retina.
-
Funded Foundation Fighting Blindness Grants and Awards for Fiscal Year 2023 (July 1, 2022–June 30, 2023)
-
First Patient Dosed in LCA5 Gene Therapy Clinical Trial Launched by Opus Genetics
Research NewsOpus was established by the RD Fund, the Foundation’s venture philanthropy arm
-
Foundation Funds 25 New Grants Totaling $15.1 Million in FY23
Research NewsThe global leader in retinal degenerative disease research supports a total of 93 research grants in its portfolio.
-
Therapeutic Targets for Dry AMD: A Foundation Fighting Blindness Webinar for Eye Care Professionals
Foundation NewsThe free, online event will feature a lecture from David Boyer, MD, a Senior Partner at Retina-Vitreous Associates Medical Group and dry AMD expert.
-
Eye on the Cure Podcast | Episode 52: Brendan Creemer
Eye on the CureSeptember 1, 2023. Brendan Creemer talks to host Ben Shaberman about how he is taking on the diagnosis of Usher syndrome 1F by dedicating his education and career to becoming a researcher for retinal disease treatments and cures.
-
SparingVision Recruiting for Clinical Trial of Cone-Preserving Gene Therapy for RP
Research NewsFirst cohort of patients has been dosed in Phase ½ clinical trial taking place in Pittsburgh and Paris
-
Atsena Doses First Patient in XLRS Gene Therapy Clinical Trial
Research NewsThe AAV.SPR gene delivery system used in the trial is designed to more safely reach targeted retinal cells
.png)
%20(11).png)
.png)
.png)
